According to a recent Boston Globe article, two vaccine officials from the U.S. Food and Drug Administration will leave the agency this fall. The two men are Marion Gruber, Ph.D., Director of FDA Office of Vaccines Research and Review, and Deputy Director Phillip Krause, M.D. Both Gruber and Kraus have been with the FDA for decades, and were key in the agency’s expedited authorization of COVID-19 vaccines amid the pandemic.
Two FDA Vaccine Officials Will Step Down This Fall
Marion Gruber, Ph.D. and Phillip Krause, M.D. were at the center of the COVID-19 vaccine authorization.
Sep 2, 2021
Sustainable Healthcare Packaging Solutions That Work
Industry leaders share proven strategies for reducing packaging emissions by up to 70% while meeting safety and regulatory requirements.
Read More
List: Digitalization Companies From PACK EXPO
Looking for CPG-focused digital transformation solutions? Download our editor-curated list from PACK EXPO featuring top companies offering warehouse management, ERP, digital twin, and MES software with supply chain visibility and analytics capabilities—all tailored specifically for CPG operations.
Download Now
Downloads


















